Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Intertumoral Heterogeneity of CD3+ and CD8+ T-Cell Densities in the Microenvironment of DNA Mismatch-Repair-Deficient Colon Cancers: Implications for Prognosis.

Yoon HH, Shi Q, Heying EN, Muranyi A, Bredno J, Ough F, Djalilvand A, Clements J, Bowermaster R, Liu WW, Barnes M, Alberts SR, Shanmugam K, Sinicrope FA.

Clin Cancer Res. 2019 Jan 1;25(1):125-133. doi: 10.1158/1078-0432.CCR-18-1984. Epub 2018 Oct 9.

PMID:
30301825
2.

Histologic parameters predictive of disease outcome in women with advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy.

Samrao D, Wang D, Ough F, Lin YG, Liu S, Menesses T, Yessaian A, Turner N, Pejovic T, Mhawech-Fauceglia P.

Transl Oncol. 2012 Dec;5(6):469-74. Epub 2012 Dec 1.

3.

The role of hypoxic-inducible factor (HIF1α) and aldolaseC protein in endometrial carcinogenesis: a retrospective study of 279 patients.

Mhawech-Fauceglia P, Wang D, Samrao D, Menesses T, Godoy H, Ough F, Lele S, Liu S, Pejovic T.

BMJ Open. 2012 Aug 24;2(4). pii: e001450. doi: 10.1136/bmjopen-2012-001450. Print 2012.

4.

Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma.

Mhawech-Fauceglia P, Wang D, Samrao D, Godoy H, Ough F, Liu S, Pejovic T, Lele S.

Gynecol Oncol. 2012 Oct;127(1):198-201. doi: 10.1016/j.ygyno.2012.06.012. Epub 2012 Jun 15.

5.

Pax-8 is a reliable marker in making the diagnosis in advanced stage epithelial ovarian carcinoma and primary peritoneal carcinoma for neoadjuvant chemotherapy on cell block and biopsy specimens.

Mhawech-Fauceglia P, Wang D, Menesses T, Chandavarkar U, Ough F, Lin Y, Liu S.

Histopathology. 2012 May;60(6):1019-20. doi: 10.1111/j.1365-2559.2011.04172.x. Epub 2012 Feb 20. No abstract available.

PMID:
22348438

Supplemental Content

Support Center